245 related articles for article (PubMed ID: 16304639)
21. Invariant NKT cells produce IL-17 through IL-23-dependent and -independent pathways with potential modulation of Th17 response in collagen-induced arthritis.
Yoshiga Y; Goto D; Segawa S; Ohnishi Y; Matsumoto I; Ito S; Tsutsumi A; Taniguchi M; Sumida T
Int J Mol Med; 2008 Sep; 22(3):369-74. PubMed ID: 18698497
[TBL] [Abstract][Full Text] [Related]
22. Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis.
Yoshiga Y; Goto D; Segawa S; Horikoshi M; Hayashi T; Matsumoto I; Ito S; Taniguchi M; Sumida T
Clin Exp Immunol; 2011 May; 164(2):236-47. PubMed ID: 21391989
[TBL] [Abstract][Full Text] [Related]
23. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
24. Effects of cyclosporin A on the activation of natural killer T cells induced by alpha-galactosylceramide.
Kajiwara T; Tomita Y; Okano S; Iwai T; Yasunami Y; Yoshikai Y; Nomoto K; Yasui H; Tominaga R
Transplantation; 2007 Jan; 83(2):184-92. PubMed ID: 17264815
[TBL] [Abstract][Full Text] [Related]
25. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
[TBL] [Abstract][Full Text] [Related]
26. Natural killer T cells ameliorate antibody-induced arthritis in macrophage migration inhibitory factor transgenic mice.
Takagi D; Iwabuchi K; Maeda M; Nakamaru Y; Furuta Y; Fukuda S; Van Kaer L; Nishihira J; Onoé K
Int J Mol Med; 2006 Nov; 18(5):829-36. PubMed ID: 17016612
[TBL] [Abstract][Full Text] [Related]
27. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
[TBL] [Abstract][Full Text] [Related]
28. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors.
Biburger M; Tiegs G
J Leukoc Biol; 2008 Jul; 84(1):264-79. PubMed ID: 18407967
[TBL] [Abstract][Full Text] [Related]
29. Enhanced tumor metastasis in response to blockade of the chemokine receptor CXCR6 is overcome by NKT cell activation.
Cullen R; Germanov E; Shimaoka T; Johnston B
J Immunol; 2009 Nov; 183(9):5807-15. PubMed ID: 19812206
[TBL] [Abstract][Full Text] [Related]
30. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia.
Michel ML; Keller AC; Paget C; Fujio M; Trottein F; Savage PB; Wong CH; Schneider E; Dy M; Leite-de-Moraes MC
J Exp Med; 2007 May; 204(5):995-1001. PubMed ID: 17470641
[TBL] [Abstract][Full Text] [Related]
31. Activation of natural killer T cells by alpha-galactosylceramide mediates clearance of bacteria in murine urinary tract infection.
Minagawa S; Ohyama C; Hatakeyama S; Tsuchiya N; Kato T; Habuchi T
J Urol; 2005 Jun; 173(6):2171-4. PubMed ID: 15879881
[TBL] [Abstract][Full Text] [Related]
32. Activation or anergy: NKT cells are stunned by alpha-galactosylceramide.
Sullivan BA; Kronenberg M
J Clin Invest; 2005 Sep; 115(9):2328-9. PubMed ID: 16138189
[TBL] [Abstract][Full Text] [Related]
33. Activation of Invariant NKT cells with glycolipid ligand α-galactosylceramide ameliorates glucose-6-phosphate isomerase peptide-induced arthritis.
Horikoshi M; Goto D; Segawa S; Yoshiga Y; Iwanami K; Inoue A; Tanaka Y; Matsumoto I; Sumida T
PLoS One; 2012; 7(12):e51215. PubMed ID: 23251456
[TBL] [Abstract][Full Text] [Related]
34. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
Fujii S; Shimizu K; Hemmi H; Steinman RM
Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
[TBL] [Abstract][Full Text] [Related]
35. Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly.
Peralbo E; DelaRosa O; Gayoso I; Pita ML; Tarazona R; Solana R
Biogerontology; 2006; 7(5-6):483-92. PubMed ID: 16953330
[TBL] [Abstract][Full Text] [Related]
36. ICOS costimulates invariant NKT cell activation.
Kaneda H; Takeda K; Ota T; Kaduka Y; Akiba H; Ikarashi Y; Wakasugi H; Kronenberg M; Kinoshita K; Yagita H; Okumura K
Biochem Biophys Res Commun; 2005 Feb; 327(1):201-7. PubMed ID: 15629449
[TBL] [Abstract][Full Text] [Related]
37. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F; He X; Iwakura Y; Horai R; Stuart JM
Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
[TBL] [Abstract][Full Text] [Related]
38. The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis.
Catalano A
J Immunol; 2010 Nov; 185(10):6373-83. PubMed ID: 20937848
[TBL] [Abstract][Full Text] [Related]
39. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
40. Activation of mouse natural killer T cells accelerates liver regeneration after partial hepatectomy.
Nakashima H; Inui T; Habu Y; Kinoshita M; Nagao S; Kawaguchi A; Miura S; Shinomiya N; Yagita H; Seki S
Gastroenterology; 2006 Nov; 131(5):1573-83. PubMed ID: 17064698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
